Chemotherapeutic drugs could generate CSCs through an NFκB-IL6-dependent inflammatory environment and result in multidrug resistance in breast cancer, but treatment with aspirin was able to disturb the nuclear translocation of NF-κB in CSCs and improve sensitivity to chemotherapy (Saha et al., 2016). The gene discussed is NFKB1; the disease is breast cancer.